Vanguard Group’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
|
|||||
|
2025
Q1 | $1.04M | Buy |
|
|||||
|
2024
Q4 | $1.32M | Buy |
|
|||||
|
2024
Q3 | $1.87M | Buy |
|
|||||
|
2024
Q2 | $9.25M | Buy |
|
|||||
|
2024
Q1 | $7.51M | Buy |
|
|||||
|
2023
Q4 | $9.23M | Buy |
|
|||||
|
2023
Q3 | $4.77M | Buy |
|
|||||
|
2023
Q2 | $7.07M | Buy |
|
|||||
|
2023
Q1 | $7.27M | Buy |
|
|||||
|
2022
Q4 | $2.81M | Buy |
|
|||||
|
2022
Q3 | $2.96M | Hold |
|
|||||
|
2022
Q2 | $1.95M | Buy |
|
|||||
|
2022
Q1 | $5.61M | Sell |
|
|||||
|
2021
Q4 | $6.34M | Buy |
|
|||||
|
2021
Q3 | $8.65M | Buy |
|
|||||
|
2021
Q2 | $7.77M | Sell |
|
|||||
|
2021
Q1 | $10.8M | Buy |
|
|||||
|
2020
Q4 | $6.86M | Buy |
|
|||||
|
2020
Q3 | $4.54M | Sell |
|
|||||
|
2020
Q2 | $6.56M | Buy |
|
|||||
|
2020
Q1 | $6.33M | Buy |
|
|||||
|
2019
Q4 | $9.1M | Buy |
|
|||||
|
2019
Q3 | $8.02M | Buy |
|
|||||
|
2019
Q2 | $5.31M | Buy |
|
|||||
|
2019
Q1 | $4.66M | Buy |
|
|||||
|
2018
Q4 | $3.3M | Buy |
|
|||||
|
2018
Q3 | $4.75M | Buy |
|
|||||
|
2018
Q2 | $549K | Buy |
|